SURF 1.07 (+0%)
US86877M2098BiotechnologyBiotechnology

Surface Oncology (SURF) Stock Highlights

1.07 | +0%
2023-10-12 18:54:28
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The companys pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out through the region of the United States.

Statistics

Range Today
1.07 1.07
Volume Today 0
Range 1 Year
0.56 1.43
Volume 1 Year 100.05M
Range 3 Year
0.56 14.4
Volume 3 Year 601.36M
Range 10 Year
0.56 18.18
Volume 10 Year 847.03M

Highlights

Market Capitalization 60.11M (small)
Floating Shares 53.23M
Current Price 1.07
Price To Earnings -0.58
Price To Book 0.79
Earnings Per Share -1.74
Payout Ratio 0%

Performance

Latest 0%
1 Month +16.3%
3 Months +42.67%
6 Months +57.35%
1 Year -20.74%
3 Years -84.05%
5 Years -89.71%
10 Years -92.75%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.